Most Recent

image: Death in the Dust

Death in the Dust

By The Scientist Staff | April 1, 2016

Follow Michele Carbone as he tracks down the genetic and environmental drivers of mesothelioma and other cancers.

1 Comment

image: Guts and Glory

Guts and Glory

By Anna Azvolinsky | April 1, 2016

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

1 Comment

image: Pulling It All Together

Pulling It All Together

By Kate Yandell | April 1, 2016

Systems-biology approaches offer new strategies for finding hard-to-identify drug targets for cancer.

0 Comments

image: Tumor Traps

Tumor Traps

By Kerry Grens | April 1, 2016

After surgery to remove a tumor, neutrophils recruited to the site spit out sticky webs of DNA that aid cancer recurrence.

0 Comments

image: A Different Way of Doing Things

A Different Way of Doing Things

By Kivanç Birsoy and David M. Sabatini | April 1, 2016

Cancer cells exhibit altered metabolic processes that may serve as promising targets for new therapies.

0 Comments

image: Metabolic Reprogramming

Metabolic Reprogramming

By Kivanç Birsoy and David M. Sabatini | April 1, 2016

How cancer cells fuel their rapid growth

0 Comments

image: The Forces of Cancer

The Forces of Cancer

By Lance L. Munn and Rakesh K. Jain | April 1, 2016

A tumor’s physical environment fuels its growth and causes treatment resistance.

0 Comments

image: Under Pressure

Under Pressure

By Lance L. Munn and Rakesh K. Jain | April 1, 2016

The causes and consequences of physical forces in the tumor microenvironment

0 Comments

image: Minimal Genome Created

Minimal Genome Created

By Ruth Williams | March 24, 2016

Scientists build a living cellular organism with a genome smaller than any known in nature.

2 Comments

Their $1.5 billion bid, which topped Thermo Fisher Scientific’s $1.3 billion offer for the genetic analysis company, was rejected.

0 Comments

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Anheuser-Busch Won’t Fund Controversial NIH Alcohol Study
  3. North American Universities Increasingly Cancel Publisher Packages
  4. CRISPR Efficiency Tied to Cancer-Causing Process